A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet (Without Water) and Conventional Tablet

Clinical trial NCT01392794 · COMPLETED

Trial details

NCT number: NCT01392794
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Plasma Concentration of YM060

Start date: 2011-04-01
Primary completion: 2011-05-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.